Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 3.75 is 12% below its 5-year average of 4.26, around the middle of its 5-year range (2.02–6.95).
As of the fiscal period ended Tuesday, June 30, 2026. 17.02% below its 12-month average of 4.52.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.75.
QUICK RATIO (ACID-TEST)
3.75
QUICK RATIO (ACID-TEST) AVG TTM
4.52
QUICK RATIO (ACID-TEST) AVG 3Y
4.65
QUICK RATIO (ACID-TEST) AVG 5Y
4.26
QUICK RATIO (ACID-TEST) AVG 10Y
4.53
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-17.02%
CURRENT VS 3Y AVG
-19.32%
CURRENT VS 5Y AVG
-12.07%
CURRENT VS 10Y AVG
-17.20%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
+11.95%
vs the sector median at left
iRhythm Technologies, Inc.
Market Cap
$3.52B
Quick Ratio (Acid-Test)
3.75
TTM Avg
4.52
3Y Avg
4.65
5Y Avg
4.26
Market Cap
$3.54B
Quick Ratio (Acid-Test)
21.02
TTM Avg
15.64
3Y Avg
20.34
5Y Avg
22.11
Market Cap
$3.48B
Quick Ratio (Acid-Test)
10.45
TTM Avg
13.16
3Y Avg
14.41
5Y Avg
11.78
Market Cap
$3.57B
Quick Ratio (Acid-Test)
50.82
TTM Avg
11.65
3Y Avg
9.40
5Y Avg
9.07
Market Cap
$3.47B
Quick Ratio (Acid-Test)
8.93
TTM Avg
9.13
3Y Avg
14.29
5Y Avg
16.91
Market Cap
$3.44B
Quick Ratio (Acid-Test)
9.61
TTM Avg
11.20
3Y Avg
9.88
5Y Avg
7.68
Market Cap
$3.64B
Quick Ratio (Acid-Test)
1.42
TTM Avg
24.66
3Y Avg
24.27
5Y Avg
16.20
Market Cap
$3.38B
Quick Ratio (Acid-Test)
3.30
TTM Avg
3.01
3Y Avg
3.08
5Y Avg
4.22
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| iRhythm Technologies, Inc. (IRTC) | $3.52B | 3.75 | 4.52 | 4.65 | 4.26 |
| Xenon Pharmaceuticals Inc. (XENE)vs › | $3.54B | 21.02 | 15.64 | 20.34 | 22.11 |
| Veracyte, Inc. (VCYT)vs › | $3.56B | 8.80 | 6.13 | 5.10 | 7.69 |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.48B | 10.45 | 13.16 | 14.41 | 11.78 |
| Tango Therapeutics, Inc. (TNGX)vs › | $3.57B | 50.82 | 11.65 | 9.40 | 9.07 |
| Celcuity Inc. (CELC)vs › | $3.47B | 8.93 | 9.13 | 14.29 | 16.91 |
| Pulse Biosciences, Inc. (PLSE)vs › | $3.44B | 9.61 | 11.20 | 9.88 | 7.68 |
| Regencell Bioscience Holdings Limited (RGC)vs › | $3.64B | 1.42 | 24.66 | 24.27 | 16.20 |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.38B | 3.30 | 3.01 | 3.08 | 4.22 |
| Parabilis Medicines, Inc. (PBLS)vs › | $3.36B | 17.91 | 1.68 | 1.68 | 1.68 |
Quick Ratio
3.75
Excludes inventory
Current Ratio
3.87
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 3.75 |
| 2026-03-31 | 4.98 |
| 2025-12-31 | 4.48 |
| 2025-09-30 | 4.50 |
| 2025-06-30 | 4.88 |
| 2025-03-31 | 5.58 |
| 2024-12-31 | 5.70 |
| 2024-09-30 | 6.12 |
| 2024-06-30 | 6.76 |
| 2024-03-31 | 6.95 |
| 2023-12-31 | 2.02 |
| 2023-09-30 | 2.16 |
| 2023-06-30 | 2.55 |
| 2023-03-31 | 2.90 |
| 2022-12-31 | 3.07 |
| 2022-09-30 | 3.25 |
| 2022-06-30 | 3.84 |
| 2022-03-31 | 4.43 |
| 2021-12-31 | 3.36 |
| 2021-09-30 | 3.81 |
| 2021-06-30 | 4.47 |
| 2021-03-31 | 5.54 |
| 2020-12-31 | 5.67 |
| 2020-09-30 | 6.46 |
| 2020-06-30 | 2.99 |
| 2020-03-31 | 3.51 |
| 2019-12-31 | 3.24 |
| 2019-09-30 | 4.07 |
| 2019-06-30 | 2.59 |
| 2019-03-31 | 3.18 |
| 2018-12-31 | 3.45 |
| 2018-09-30 | 4.69 |
| 2018-06-30 | 5.47 |
| 2018-03-31 | 6.48 |
| 2017-12-31 | 5.64 |
| 2017-09-30 | 7.57 |
| 2017-06-30 | 8.07 |
| 2017-03-31 | 9.88 |
| 2016-12-31 | 8.87 |
| 2016-09-30 | 1.73 |
| 2016-06-30 | 2.38 |
| 2016-03-31 | 0.00 |
| 2015-12-31 | 3.61 |
| 2015-09-30 | 2.02 |
| 2015-06-30 | 0.00 |
| 2015-03-31 | 0.00 |
| 2014-12-31 | 3.03 |
